Christopher D. M. Fletcher

Christopher D. M. Fletcher's AcademicInfluence.com Rankings

Biology

#2205

World Rank

#3531

Historical Rank

Pathology

#16

World Rank

#41

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Christopher D. M. Fletcher Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Christopher D. M. Fletcher's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Pathology and genetics of tumours of soft tissue and bone (2002) (4672)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. (2002) (4091)
Diagnosis of gastrointestinal stromal tumors: A consensus approach. (2002) (3533)
WHO classification of tumours of soft tissue and bone (2013) (3462)
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors (2003) (2321)
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. (2003) (2202)
Soft Tissue Tumors (1998) (2173)
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial (2012) (1608)
KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. (2001) (988)
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. (2008) (942)
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. (2008) (931)
Inflammatory Myofibroblastic Tumor: Comparison of Clinicopathologic, Histologic, and Immunohistochemical Features Including ALK Expression in Atypical and Aggressive Cases (2007) (784)
Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. (2006) (763)
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications (2001) (696)
WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition (2014) (678)
PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies (2013) (672)
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. (2008) (662)
Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. (1998) (653)
BRAF Mutations Are Sufficient to Promote Nevi Formation and Cooperate with p53 in the Genesis of Melanoma (2005) (651)
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. (2000) (650)
TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. (2000) (649)
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. (2007) (623)
Management of malignant gastrointestinal stromal tumours. (2002) (578)
tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. (2005) (576)
Diagnostic histopathology of tumors (2013) (562)
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. (2008) (559)
Soft tissue sarcomas of adults: state of the translational science. (2003) (559)
Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics (2014) (540)
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases (2006) (527)
Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma. (1999) (519)
The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification (2014) (513)
KIT-Negative Gastrointestinal Stromal Tumors: Proof of Concept and Therapeutic Implications (2004) (502)
Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. (1996) (499)
Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma (2009) (493)
Myoepithelial Tumors of Soft Tissue: A Clinicopathologic and Immunohistochemical Study of 101 Cases With Evaluation of Prognostic Parameters (2003) (489)
Soft tissue tumours (1989) (480)
PEComa: what do we know so far? (2006) (455)
"Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. (1997) (454)
Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. (2002) (446)
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. (2006) (436)
EWSR1‐POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene (2010) (411)
Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. (2000) (404)
Pleomorphic Malignant Fibrous Histiocytoma: Fact or Fiction? A Critical Reappraisal Based on 159 Tumors Diagnosed as Pleomorphic Sarcoma (1992) (399)
Novel YAP1‐TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma (2013) (397)
The evolving classification of soft tissue tumours: an update based on the new WHO classification (2006) (385)
Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. (1997) (374)
Follicular dendritic cell sarcoma (1997) (343)
Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. (1996) (341)
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. (2010) (338)
Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. (1998) (335)
Solitary fibrous tumour arising at unusual sites: analysis of a series (1991) (332)
Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs) (2004) (332)
Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. (2001) (328)
Angiomyofibroblastoma of the Vulva: A Benign Neoplasm Distinct from Aggressive Angiomyxoma (1992) (328)
Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. (2002) (320)
Dedifferentiated Liposarcoma Clinicopathologic Analysis of 32 Cases Suggesting a Better Prognostic Subgroup Among Pleomorphic Sarcomas (1994) (305)
Pleomorphic Malignant Fibrous Histiocytoma: Fact or Fiction? (1992) (300)
MUC4 Is a Highly Sensitive and Specific Marker for Low-grade Fibromyxoid Sarcoma (2011) (298)
Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors. (1998) (281)
Coordinated expression and amplification of the MDM2, CDK4, and HMGI‐C genes in atypical lipomatous tumours (2000) (277)
Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene (2005) (271)
Epithelioid Inflammatory Myofibroblastic Sarcoma: An Aggressive Intra-abdominal Variant of Inflammatory Myofibroblastic Tumor With Nuclear Membrane or Perinuclear ALK (2011) (269)
Extranodal Histiocytic Sarcoma: Clinicopathologic Analysis of 14 Cases of a Rare Epithelioid Malignancy (2004) (268)
Epithelioid Angiosarcoma of Deep Soft Tissue: A Distinctive Tumor Readily Mistaken for an Epithelial Neoplasm (1991) (264)
Cutaneous soft tissue sarcoma incidence patterns in the U.S. (2008) (260)
Monoclonal Antibody DOG1.1 Shows Higher Sensitivity Than KIT in the Diagnosis of Gastrointestinal Stromal Tumors, Including Unusual Subtypes (2009) (257)
Mixed tumors and myoepitheliomas of soft tissue: a clinicopathologic study of 19 cases with a unifying concept. (1997) (255)
EWSR1‐CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma (2007) (247)
Gastrointestinal stromal tumors (2010) (243)
Cellular angiofibroma: a benign neoplasm distinct from angiomyofibroblastoma and spindle cell lipoma. (1997) (240)
Soft Tissue Perineurioma: Clinicopathologic Analysis of 81 Cases Including Those With Atypical Histologic Features (2005) (237)
Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases (2017) (229)
Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis (2007) (227)
Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease. (2000) (225)
Pleomorphic Liposarcoma: Clinicopathologic Analysis of 57 Cases (2004) (224)
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. (2017) (221)
Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement (2015) (220)
Expanding the Spectrum of Malignant Progression in Solitary Fibrous Tumors: A Study of 8 Cases With a Discrete Anaplastic Component—Is This Dedifferentiated SFT? (2009) (215)
Retiform Hemangioendothelioma: A Distinctive Form of Low‐Grade Angiosarcoma Delineated in a Series of 15 Cases (1994) (215)
Spindle Cell (Sarcomatoid) Carcinoma of the Breast: A Clinicopathologic and Immunohistochemical Analysis of 29 Cases (2006) (215)
Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. (1998) (214)
Cutaneous Rosai-Dorfman Disease Is a Distinct Clinical Entity (2002) (212)
QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections (1990) (212)
Cellular Benign Fibrous Histiocytoma: Clinicopathologic Analysis of 74 Cases of a Distinctive Variant of Cutaneous Fibrous Histiocytoma with Frequent Recurrence (1994) (211)
Radiation-Associated Cutaneous Atypical Vascular Lesions and Angiosarcoma: Clinicopathologic Analysis of 42 Cases (2005) (209)
Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics (2016) (208)
Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. (1995) (208)
MUC4 Is a Sensitive and Extremely Useful Marker for Sclerosing Epithelioid Fibrosarcoma: Association With FUS Gene Rearrangement (2012) (207)
Pseudomyogenic Hemangioendothelioma: A Distinctive, Often Multicentric Tumor With Indolent Behavior (2011) (207)
Myoepithelial Carcinoma of Soft Tissue in Children: An Aggressive Neoplasm Analyzed in a Series of 29 Cases (2007) (207)
Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity (1995) (207)
Immunohistochemistry for β‐catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature (2007) (207)
Spindle cell lipoma: a clinicopathological study with some original observations (1987) (202)
Cellular Angiofibroma: Clinicopathologic and Immunohistochemical Analysis of 51 Cases (2004) (200)
Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. (1999) (190)
Distinct transcriptional signature and immunoprofile of CIC‐DUX4 fusion–positive round cell tumors compared to EWSR1‐rearranged ewing sarcomas: Further evidence toward distinct pathologic entities (2014) (190)
Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). (1996) (188)
The chimeric FUS/CREB3l2 gene is specific for low‐grade fibromyxoid sarcoma (2004) (188)
NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines. (2004) (188)
Malignant myopericytoma: expanding the spectrum of tumours with myopericytic differentiation. (2002) (184)
Superficial angiomyxoma: clinicopathologic analysis of a series of distinctive but poorly recognized cutaneous tumors with tendency for recurrence. (1999) (183)
Phase II study of imatinib in patients with small cell lung cancer. (2003) (183)
Cellular Neurothekeoma: Detailed Characterization in a Series of 133 Cases (2007) (181)
Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics (2016) (179)
Pure Epithelioid PEComas (So-Called Epithelioid Angiomyolipoma) of the Kidney: A Clinicopathologic Study of 41 Cases: Detailed Assessment of Morphology and Risk Stratification (2011) (179)
Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. (1990) (179)
Aggressive angiomyxoma: reappraisal of its relationship to angiomyofibroblastoma in a series of 16 cases (1997) (177)
Loss of Retinoblastoma Protein Expression in Spindle Cell/Pleomorphic Lipomas and Cytogenetically Related Tumors: An Immunohistochemical Study With Diagnostic Implications (2012) (176)
Mammary-Type Myofibroblastoma of Soft Tissue: A Tumor Closely Related to Spindle Cell Lipoma (2001) (175)
EWSR1-CREB1 and EWSR1-ATF1 Fusion Genes in Angiomatoid Fibrous Histiocytoma (2007) (175)
The role of KIT in the management of patients with gastrointestinal stromal tumors. (2007) (170)
Infantile Hemangiopericytoma Versus Infantile Myofibromatosis Study of a Series Suggesting a Continuous Spectrum of Infantile Myofibroblastic Lesions (1994) (170)
Glomeruloid Hemangioma A Distinctive Cutaneous Lesion of Multicentric Castleman's Disease Associated with POEMS Syndrome (1990) (170)
Management of soft-tissue sarcomas: an overview and update. (2000) (170)
Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: A report of the CHAMP study group (1998) (169)
Diagnosis of Gastrointestinal Stromal Tumors:A Consensus Approach (2002) (165)
BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas (2017) (165)
Molecular Insights into the Histogenesis and Pathogenesis of Gastrointestinal Stromal Tumors (2000) (164)
Cutaneous myoepithelioma: a clinicopathologic and immunohistochemical study of 14 cases. (2004) (164)
Malignant Epithelioid Angiomyolipoma (`Sarcoma Ex Angiomyolipoma') of the Kidney: A Case Report and Review of the Literature (2001) (163)
Expanding the Spectrum of Malignant Change in Schwannomas: Epithelioid Malignant Change, Epithelioid Malignant Peripheral Nerve Sheath Tumor, and Epithelioid Angiosarcoma: A Study of 17 Cases (2001) (161)
Cellular pseudosarcomatous fibroepithelial stromal polyps of the lower female genital tract: an underrecognized lesion often misdiagnosed as sarcoma. (2000) (159)
Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA) (1991) (156)
Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors (2016) (156)
Spindle Cell Rhabdomyosarcoma in Adults (2005) (155)
Hybrid Schwannoma/Perineurioma: Clinicopathologic Analysis of 42 Distinctive Benign Nerve Sheath Tumors (2009) (155)
A novel SERPINE1–FOSB fusion gene results in transcriptional up‐regulation of FOSB in pseudomyogenic haemangioendothelioma (2014) (154)
Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma. (1990) (154)
Cellular schwannoma: a distinct pseudosarcomatous entity (1987) (151)
Smooth muscle tumours of the external genitalia: clinicopathological analysis of a series (1991) (147)
Gastrointestinal Stromal Tumours: An Update (1998) (146)
Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differential diagnosis. (1999) (145)
Intramuscular and intermuscular lipoma: neglected diagnoses (1988) (143)
Primary Angiosarcoma of the Breast: Clinicopathologic Analysis of 49 Cases, Suggesting That Grade is not Prognostic (2008) (142)
Primary Vascular Tumors of Lymph Nodes Other Than Kaposi's Sarcoma: Analysis of 39 Cases and Delineation of Two New Entities (1992) (142)
Atypical Fibrous Histiocytoma of the Skin: Clinicopathologic Analysis of 59 Cases With Evidence of Infrequent Metastasis (2002) (140)
Spindle Cell Liposarcoma, A Hitherto Unrecognized Variant of Liposarcoma Analysis of Six Cases (1994) (138)
Aneurysmal benign fibrous histiocytoma: clinicopathological analysis of 40 cases of a tumour frequently misdiagnosed as a vascular neoplasm (1995) (137)
Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome. (1999) (135)
Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling (2009) (134)
Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. (1993) (134)
CD99 reactivity in mesenchymal chondrosarcoma. (1996) (134)
Pleomorphic Rhabdomyosarcoma in Adulthood: Analysis of 11 Cases with Definition of Diagnostic Criteria (1993) (133)
Immunohistochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: A systematic study of 100 cases (2000) (132)
Dystrophin Is a Tumor Suppressor in Human Cancers with Myogenic Programs (2014) (131)
Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas (2016) (130)
Dose effect of imatinib (IM) in patients (pts) with metastatic GIST - Phase III Sarcoma Group Study S0033. (2004) (130)
Malignant fibrous histiocytoma: morphologic pattern or pathologic entity? (1995) (128)
Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature (1985) (127)
Spindle cell haemangioendothelioma: a clinicopathological and immunohistochemical study indicative of a non‐neoplastic lesion (1991) (127)
Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor (2011) (126)
Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure (2009) (126)
Myoepithelial Neoplasms of Soft Tissue: An Updated Review of the Clinicopathologic, Immunophenotypic, and Genetic Features (2015) (125)
Primary pleuropulmonary synovial sarcoma (2002) (125)
Aggressive Angiomyxoma: A Report of Four Cases Occurring in Men (1992) (124)
Frequent FOS Gene Rearrangements in Epithelioid Hemangioma: A Molecular Study of 58 Cases With Morphologic Reappraisal (2015) (124)
FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma (2017) (123)
Reticular Perineurioma: A Distinctive Variant of Soft Tissue Perineurioma (2001) (122)
Sclerosing PEComa: Clinicopathologic Analysis of a Distinctive Variant With a Predilection for the Retroperitoneum (2008) (122)
Angiomatoid "malignant fibrous histiocytoma": an immunohistochemical study indicative of myoid differentiation. (1991) (121)
Mammary-type Myofibroblastoma: Clinicopathologic Characterization in a Series of 143 Cases (2016) (121)
Intestinal Perineuriomas: Clinicopathologic Definition of a New Anatomic Subset in a Series of 10 Cases (2005) (120)
Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma (2016) (120)
Digital Fibromyxoma (Superficial Acral Fibromyxoma): A Detailed Characterization of 124 Cases (2012) (120)
A novel group of spindle cell tumors defined by S100 and CD34 co‐expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes (2018) (118)
Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. (2007) (118)
Protein Kinase C θ (PKCθ) Expression and Constitutive Activation in Gastrointestinal Stromal Tumors (GISTs) (2004) (118)
A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AGNOR) staining, and histological grading in gastrointestinal stromal tumours (1992) (118)
Evaluation of pan‐TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis‐like neural tumour and histological mimics (2018) (118)
Clonal Evolution of Resistance to Imatinib in Patients with Metastatic Gastrointestinal Stromal Tumors (2007) (118)
Composite hemangioendothelioma: a complex, low-grade vascular lesion mimicking angiosarcoma. (2000) (117)
Dedifferentiated Liposarcoma With “Homologous” Lipoblastic (Pleomorphic Liposarcoma-like) Differentiation: Clinicopathologic and Molecular Analysis of a Series Suggesting Revised Diagnostic Criteria (2010) (117)
Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group. (1999) (117)
Clinically Relevant Molecular Subtypes in Leiomyosarcoma (2015) (117)
Results from a continuation trial of SU11248 in patients (pts) with imatinib (IM)-resistant gastrointestinal stromal tumor (GIST) (2005) (117)
Analysis of 35 cases of localized and diffuse tenosynovial giant cell tumor: a report from the Chromosomes and Morphology (CHAMP) study group. (1999) (117)
Genome‐wide transcriptome analyses reveal p53 inactivation mediated loss of miR‐34a expression in malignant peripheral nerve sheath tumours (2010) (116)
Surgical resection of primary soft-tissue sarcoma. Incidence of residual tumour in 95 patients needing re-excision after local resection. (1996) (116)
ZFP36‐FOSB fusion defines a subset of epithelioid hemangioma with atypical features (2014) (115)
Atypical Intradermal Smooth Muscle Neoplasms: Clinicopathologic Analysis of 84 Cases and a Reappraisal of Cutaneous “Leiomyosarcoma” (2011) (115)
“Juvenile” Xanthogranuloma: An Immunophenotypic Study With A Reappraisal of Histogenesis (2001) (114)
Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group (2002) (114)
Cutaneous pilar leiomyoma: clinicopathologic analysis of 53 lesions in 45 patients. (1997) (114)
Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation (2013) (113)
Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors. (2012) (113)
Postradiation vascular proliferations: an increasing problem (2006) (113)
Extranodal follicular dendritic cell sarcoma of the gastrointestinal tract. Morphologic, immunohistochemical and ultrastructural analysis of two cases. (1995) (113)
Calcifying Fibrous ‘Pseudotumor’ (2002) (112)
Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes (2012) (111)
Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features (1997) (110)
Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). (2004) (110)
Atypical and Malignant Variants of Ossifying Fibromyxoid Tumor: Clinicopathologic Analysis of Six Cases (1995) (109)
Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics (2016) (109)
SU11248, a multi-targeted tyrosine kinase inhibitor, can overcome imatinib (IM) resistance caused by diverse genomic mechanisms in patients (pts) with metastatic gastrointestinal stromal tumor (GIST). (2004) (109)
Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material (2014) (108)
Epithelioid Malignant Peripheral Nerve Sheath Tumor: Clinicopathologic Analysis of 63 Cases (2015) (107)
Primary cutaneous Ewing's sarcoma: immunophenotypic and molecular cytogenetic evaluation of five cases. (1998) (107)
Dedifferentiated liposarcoma: a report of nine cases with a peculiar neurallike whorling pattern associated with metaplastic bone formation. (1998) (106)
Inflammatory pseudotumour of soft tissues: a clinicopathological and immunohistochemical analysis of 18 cases (1995) (106)
Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases. (1998) (106)
Plexiform fibrohistiocytic tumour: clinicopathological, immunohistochemical and ultrastructural analysis in favour of a myofibroblastic lesion (1991) (106)
Cytogenetic-Morphologic Correlations in Aneurysmal Bone Cyst, Giant Cell Tumor of Bone and Combined Lesions. A Report from the CHAMP Study Group (2000) (106)
Cytogenetic, Clinical, and Morphologic Correlations in 78 Cases of Fibromatosis: A Report from the CHAMP Study Group (2000) (105)
Well-differentiated inflammatory liposarcoma: an uncommon and easily overlooked variant of a common sarcoma. (1997) (105)
Reactive Angioendotheliomatosis: A Study of 15 Cases Demonstrating a Wide Clinicopathologic Spectrum (2002) (104)
Schwannomas of the sinonasal tract and nasopharynx. (1997) (103)
Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma (2002) (103)
Cutaneous Epithelioid Angiomatous Nodule: A Distinct Lesion in the Morphologic Spectrum of Epithelioid Vascular Tumors (2004) (103)
Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor. (2001) (103)
Solitary myofibroma in adults: clinicopathological analysis of a series (1993) (103)
Epithelioid benign fibrous histiocytoma of skin: clinico‐pathological analysis of 20 cases of a poorly known variant (1994) (102)
Haemangiopericytoma — A dying breed? Reappraisal of an ‘entity’ and its variants: a hypothesis (1994) (102)
Leiomyoma of Deep Soft Tissue: Clinicopathologic Analysis of a Series (1994) (102)
Combined morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing, (a report from the CHAMP Group). (1996) (101)
Translocation t(7;19)(q22;q13)−a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma? (2011) (101)
Primary liposarcoma of the skin: a rare neoplasm with unusual high grade features. (1998) (99)
Myxoid Dermatofibrosarcoma Protuberans: A Rare Variant Analyzed in a Series of 23 Cases (2007) (98)
Lipomatous tumours of soft tissues: an update (2004) (97)
Hobnail hemangioma: a pseudomalignant vascular lesion with a reappraisal of targetoid hemosiderotic hemangioma. (1999) (97)
Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma (2014) (97)
t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases. (1995) (95)
Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: clinicopathologic analysis of 5 cases (1996) (95)
Sunitinib (SU) response in imatinib-resistant (IM-R) GIST correlates with KIT and PDGFRA mutation status. (2006) (94)
Atypical Spindle Cell Lipomatous Tumor: Clinicopathologic Characterization of 232 Cases Demonstrating a Morphologic Spectrum (2017) (94)
Angiosarcoma Arising in Hemangioma/Vascular Malformation: Report of Four Cases and Review of the Literature (2002) (94)
Perineurioma (storiform perineurial fibroma) (1994) (94)
Infantile myofibromatosis: a light microscopic, histochemical and immunohistochemical study suggesting true smooth muscle differentiation (1987) (94)
Primary Mediastinal Liposarcoma: Clinicopathologic Analysis of 24 Cases (2007) (93)
Deciduoid Peritoneal Mesothelioma: An Unusual Phenotype Affecting Young Females (1994) (93)
A subset of cutaneous and soft tissue mixed tumors are genetically linked to their salivary gland counterpart (2012) (93)
Gardner Fibroma: A Clinicopathologic and Immunohistochemical Analysis of 45 Patients With 57 Fibromas (2007) (93)
Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas (1998) (93)
Primitive Nonneural Granular Cell Tumors of Skin: Clinicopathologic Analysis of 13 Cases (2005) (93)
Cutaneous Fibrohistiocytic Tumors: An Update (1994) (92)
Distinctive Cytogenetic Profile in Benign Metastasizing Leiomyoma: Pathogenetic Implications (2007) (92)
Benign plexiform (multinodular) schwannoma: a rare tumour unassociated with neurofibromatosis (1986) (91)
Cutaneous Syncytial Myoepithelioma: Clinicopathologic Characterization in a Series of 38 Cases (2013) (91)
Pathologic Characteristics of NUT Midline Carcinoma Arising in the Mediastinum (2012) (90)
Targeted Expression of Human MYCN Selectively Causes Pancreatic Neuroendocrine Tumors in Transgenic Zebrafish (2004) (90)
ALK rearrangement and overexpression in epithelioid fibrous histiocytoma (2015) (90)
p53 protein expression in non‐neoplastic lesions and benign and malignant neoplasms of soft tissue (1993) (90)
Deep “Benign” Fibrous Histiocytoma: Clinicopathologic Analysis of 69 Cases of a Rare Tumor Indicating Occasional Metastatic Potential (2008) (90)
Phase II Study of the Antiangiogenic Agent SU5416 in Patients with Advanced Soft Tissue Sarcomas (2004) (89)
Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. (2000) (89)
Carcinosarcoma Arising in Eccrine Spiradenoma: A Clinicopathologic and Immunohistochemical Study of Two Cases (1990) (89)
Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis-the SIN-system. (2003) (89)
Splenic vascular tumors. (2003) (89)
Microphthalmia Transcription Factor: Not A Sensitive or Specific Marker for the Diagnosis of Desmoplastic Melanoma and Spindle Cell (Non-Desmoplastic) Melanoma (2001) (87)
Cellular Angiofibroma With Atypia or Sarcomatous Transformation: Clinicopathologic Analysis of 13 Cases (2010) (87)
Cellular ‘neurothekeoma’: an epithelioid variant of pilar eiomyoma? Morphological and immunohistochemical analysis of a series (1992) (87)
Liposarcomas/atypical lipomatous tumors of the oral cavity: a clinicopathologic study of 23 cases. (2002) (86)
Primary Cutaneous PEComa: Distinctive Clear Cell Lesions of Skin (2008) (84)
IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link? (2011) (84)
Metastatic malignant melanoma showing a rhabdoid phenotype: further evidence of a non‐specific histological pattern (1992) (83)
Cytogenetic analysis of subcutaneous angiolipoma: further evidence supporting its difference from ordinary pure lipomas: a report of the CHAMP Study Group. (1997) (83)
Pigmented dermatofibrosarcoma protuberans (Bednar tumour): melanocytic colonization or neuroectodermal differentiation? A clinicopathological and immunohistochemical study (1988) (83)
NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018. (2017) (83)
Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. (1998) (82)
Inflammatory myofibroblastic tumor of bone: report of two cases with evidence of clonal chromosomal changes. (1997) (82)
Recurrent MALAT1–GLI1 oncogenic fusion and GLI1 up‐regulation define a subset of plexiform fibromyxoma (2016) (82)
Structural alterations of the RB1 gene in human soft tissue tumours. (1989) (82)
Dedifferentiation in Gastrointestinal Stromal Tumor to an Anaplastic KIT-negative Phenotype: A Diagnostic Pitfall Morphologic and Molecular Characterization of 8 Cases Occurring Either De Novo or After Imatinib Therapy (2013) (82)
ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tract (2006) (82)
Solitary Circumscribed Neuroma of the Skin (So‐called Palisaded, Encapsulated Neuroma): A Clinicopathologic and Immunohistochemical Study (1989) (81)
Biology of Gastrointestinal Stromal Tumors: KIT Mutations and Beyond (2004) (81)
p63 immunohistochemical staining is limited in soft tissue tumors. (2011) (81)
Spindle cell rhabdomyosarcoma (so-called) in adults: report of two cases with emphasis on differential diagnosis. (1998) (80)
Well‐differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases (2013) (80)
EWSR1‐PBX3: A novel gene fusion in myoepithelial tumors (2015) (80)
Microcystic/Reticular Schwannoma: A Distinct Variant With Predilection for Visceral Locations (2008) (79)
Novel FUS‐KLF17 and EWSR1‐KLF17 fusions in myoepithelial tumors (2015) (79)
Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series. (2000) (79)
Primary metaplastic carcinoma (carcinosarcoma) of the skin. A clinicopathologic study of four cases and review of the literature. (1997) (79)
Spindle‐cell non‐pleomorphic atypical fibroxanthoma: analysis of a series and delineation of a distinctive variant (1993) (78)
A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma (2020) (78)
Malignant Mesenchymoma Clinicopathologic Analysis of a Series With Evidence of Low‐Grade Behaviour (1991) (78)
Sinusoidal Hemangioma: A Distinctive Benign Vascular Neoplasm Within the Group of Cavernous Hemangiomas (1991) (78)
Rhabdomyosarcomatous Differentiation in Gastrointestinal Stromal Tumors After Tyrosine Kinase Inhibitor Therapy: A Novel Form of Tumor Progression (2009) (77)
Epithelioid Variant of Myxofibrosarcoma: Expanding the Clinicomorphologic Spectrum of Myxofibrosarcoma in a Series of 17 Cases (2007) (77)
Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma. (2010) (76)
Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs). (2004) (76)
PEComa of the Gastrointestinal Tract: Clinicopathologic Study of 35 Cases With Evaluation of Prognostic Parameters (2013) (76)
Distinctive Prepubertal Vulval Fibroma: A Hitherto Unrecognized Mesenchymal Tumor of Prepubertal Girls: Analysis of 11 Cases (2004) (75)
Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma (2008) (74)
Multimodality treatment of mesenteric desmoid tumours. (2008) (74)
Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma (2017) (74)
Soft Tissue Aneurysmal Bone Cyst: A Clinicopathologic Study of Five Cases (2002) (74)
Angiofibroma of Soft Tissue: Clinicopathologic Characterization of a Distinctive Benign Fibrovascular Neoplasm in a Series of 37 Cases (2012) (73)
Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate (2010) (73)
Eosinophilia in squamous cell carcinoma of the oral cavity, external genitalia and anus—clinical correlations (1984) (73)
Metastasizing “Benign” Cutaneous Fibrous Histiocytoma: A Clinicopathologic Analysis of 16 Cases (2013) (73)
Cellular myxoma of soft tissue: a clinicopathological study of 38 cases confirming indolent clinical behaviour (2001) (73)
The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements (2019) (72)
The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma (2000) (72)
Primary liposarcoma of the orbit: a clinicopathologic study of seven cases. (2001) (71)
TERT promoter mutations and prognosis in solitary fibrous tumor (2016) (71)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. (2020) (71)
Translocation t(12;22)(q13;q13) is a nonrandom rearrangement in clear cell sarcoma. (1992) (70)
Protocol for the examination of specimens from patients with gastrointestinal stromal tumor. (2010) (70)
Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms (2016) (70)
Giant cell fibroblastoma of soft tissue: a clinicopathological and immunohistochemical study (1988) (70)
Malignant Fat-Forming Solitary Fibrous Tumor (so-called “Lipomatous Hemangiopericytoma”): Clinicopathologic Analysis of 14 Cases (2011) (69)
Myxoid synovial sarcoma: an underappreciated morphologic subset. (1999) (69)
Leiomyosarcoma of soft tissue in children: clinicopathologic analysis of 20 cases. (1999) (69)
Cytogenetic evidence of clonality in cutaneous benign fibrous histiocytomas: a report of the CHAMP Study Group (2000) (69)
Protein kinase C-θ regulates KIT expression and proliferation in gastrointestinal stromal tumors (2008) (68)
Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas. (1994) (68)
Haemosiderotic fibrolipomatous tumour (so‐called haemosiderotic fibrohistiocytic lipomatous tumour): analysis of 13 new cases in support of a distinct entity (2006) (68)
Epithelioid Rhabdomyosarcoma: Clinicopathologic Analysis of 16 Cases of a Morphologically Distinct Variant of Rhabdomyosarcoma (2011) (68)
Myxoid Variant of So-called Angiomatoid “Malignant Fibrous Histiocytoma”: Clinicopathologic Characterization in a Series of 21 Cases (2014) (67)
Intradermal Spindle Cell/Pleomorphic Lipoma: A Distinct Subset (2000) (67)
Myxoid leiomyosarcoma of soft tissue, an underrecognized variant. (2000) (67)
Distinctive Soft Tissue Tumors of the Head and Neck (2002) (67)
Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2, with implications for the histologic sub-classification of synovial sarcoma. (1995) (66)
Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing (2015) (64)
Lipidized fibrous histiocytoma: clinicopathologic analysis of 22 cases. (2000) (64)
Myeloproliferative neoplasms, version 2.2018 featured Updates to the NCCN guidelines (2017) (64)
Spindle cell and pleomorphic lipoma: An immunohistochemical study and histogenetic analysis (1989) (64)
Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group (2000) (64)
Clear Cell Sarcoma Shows Immunoreactivity for Microphthalmia Transcription Factor: Further Evidence for Melanocytic Differentiation (2001) (63)
Spindle Cell Tumors With RET Gene Fusions Exhibit a Morphologic Spectrum Akin to Tumors With NTRK Gene Fusions (2019) (63)
Dedifferentiated myxoid liposarcoma: a clinicopathological study suggesting a closer relationship between myxoid and well‐differentiated liposarcoma (1997) (62)
Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas (2017) (62)
Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genes (2016) (62)
Ancient hematoma: a unifying concept for a post-traumatic lesion mimicking an aggressive soft tissue neoplasm. (1997) (62)
Effi cacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial (2006) (61)
Round cell sarcomas - biologically important refinements in subclassification. (2014) (61)
Primary Sclerosing Epithelioid Fibrosarcoma of Bone: Analysis of a Series (2014) (61)
Malignant nerve sheath tumour arising in a benign ancient schwannoma (1989) (61)
Sarcomatoid tumours of lymph nodes showing follicular dendritic cell differentiation (1991) (60)
Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix (2009) (60)
The cytogenetics of lipomatous tumours (1997) (60)
Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era (2014) (60)
Intraabdominal cystic lymphangiomas obscured by marked superimposed reactive changes: clinicopathological analysis of a series. (2005) (60)
A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions (2017) (59)
Comparative cytogenetic study of spindle cell and pleomorphic leiomyosarcomas of soft tissues: a report from the CHAMP Study Group. (2000) (59)
Epithelial membrane antigen expression by the perineurial cell: further studies of peripheral nerve lesions (1989) (59)
Rhabdomyosarcoma in adults. (1994) (58)
Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma (2019) (58)
Intraarticular Nodular Fasciitis-A Rare Lesion: Clinicopathologic Analysis of a Series (2006) (57)
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. (2006) (57)
Angiosarcoma of the ovary: clinicopathologic and immunohistochemical analysis of four cases with a broad morphologic spectrum. (1998) (57)
Dermal nerve sheath myxoma: a study of three cases (1986) (57)
Myofibroblastic tumours: an update. (1998) (56)
Comparison of chromosomal patterns with clinical features in 165 lipomas: a report of the CHAMP study group. (1998) (56)
Trisomies 8 and 20 in desmoid tumors. (1996) (56)
Fibrous Lesions of the Breast (2000) (56)
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019. (2017) (55)
Lymphangiomatosis of the limbs. Clinicopathologic analysis of a series with a good prognosis. (1995) (55)
The emerging role of myofibroblasts in soft tissue neoplasia. (1997) (55)
Intranodal myofibroblastoma presenting in the submandibular region: evidence of a broader clinical and histological spectrum (1990) (55)
Peripheral Hemangioblastoma: Clinicopathologic Characterization in a Series of 22 Cases (2014) (55)
Criteria for malignancy in nonvisceral smooth muscle tumors. (2003) (54)
SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities (2019) (54)
Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases (2018) (54)
Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score. (2017) (54)
Malignant peripheral nerve sheath tumours. (1995) (54)
Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities (2021) (53)
Myopericytomatosis: Clinicopathologic Analysis of 11 Cases With Molecular Identification of Recurrent PDGFRB Alterations in Myopericytomatosis and Myopericytoma (2017) (53)
True histiocytic lymphoma of small intestine. Analysis of two S-100 protein-positive cases with features of interdigitating reticulum cell sarcoma. (1993) (53)
Sclerosing Paraganglioma: Report of 19 Cases of an Unusual Variant of Neuroendocrine Tumor That May Be Mistaken for an Aggressive Malignant Neoplasm (2006) (53)
Aberrant AKT activation drives well-differentiated liposarcoma (2011) (52)
Synovial sarcoma in older patients: clinicopathological analysis of 32 cases with emphasis on unusual histological features (2003) (52)
Dermatofibrosarcoma protuberans with a novel COL6A3‐PDGFD fusion gene and apparent predilection for breast (2018) (52)
Liposarcoma (Atypical Lipomatous Tumors) of the Vulva A Clinicopathologic Study of Six Cases (1998) (52)
Myxoid chondrosarcoma (chordoid sarcoma) of bone (1997) (52)
SMARCB1/INI1 Loss in Epithelioid Schwannoma: A Clinicopathologic and Immunohistochemical Study of 65 Cases (2017) (52)
A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis, and growth pattern (2011) (51)
Tenosynovial giant cell tumors: evidence for a desmin-positive dendritic cell subpopulation. (1998) (51)
Adult and infantile myofibromatosis: a report of three cases affecting the oral cavity. (1991) (51)
Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma: A Potential Diagnostic Pitfall With Sarcomas With Myogenic Differentiation (2017) (50)
Recommendations for the reporting of soft tissue sarcoma (1999) (49)
Atypical ‘pseudosarcomatous’ variant of cutaneous benign fibrous histiocytoma: report of eight cases (1990) (49)
KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance (2007) (49)
Heterogeneous genetic profiles in soft tissue myoepitheliomas (2008) (48)
R132C IDH1 mutations are found in spindle cell hemangiomas and not in other vascular tumors or malformations. (2013) (48)
Dedifferentiated leiomyosarcoma: clinicopathological analysis of 18 cases (2011) (47)
Expression of Programmed Cell Death 1 Ligands (PD-L1 and PD-L2) in Histiocytic and Dendritic Cell Disorders (2016) (47)
Distinct histological features characterize primary angiosarcoma of bone (2011) (47)
EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall (2011) (47)
Extraskeletal Myxoid Chondrosarcoma: An Immunohistochemical Reappraisal of 39 Cases (1997) (47)
Recurrent PRDM10 Gene Fusions in Undifferentiated Pleomorphic Sarcoma (2014) (47)
Recurrent chromosome aberrations in fibrous dysplasia of the bone: a report of the CHAMP study group. CHromosomes And MorPhology. (2000) (46)
MOLECULAR ABNORMALITIES OF THE p53 PATHWAY IN DEDIFFERENTIATED LIPOSARCOMA (1997) (46)
Fibrous hamartoma of infancy: a histochemical and immunohistochemical study (1988) (46)
Epigenetic regulation of SMARCB1 By miR‐206, ‐381 and ‐671‐5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR‐765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas (2016) (46)
Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma. (2009) (46)
Immunohistochemistry of MyoD1 in Adult Pleomorphic Soft Tissue Sarcomas (1995) (46)
Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin? (2009) (45)
Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney (2015) (45)
A Reappraisal of Hemangiopericytoma of Bone; Analysis of Cases Reclassified as Synovial Sarcoma and Solitary Fibrous Tumor of Bone (2010) (45)
Pseudosarcomatous Myofibroblastic Proliferations of the Spermatic Cord (“Proliferative Funiculitis”): Histologic and Immunohistochemical Analysis of a Distinctive Entity (1992) (44)
PEComa Presenting in Bone: Clinicopathologic Analysis of 6 Cases and Literature Review (2010) (44)
Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis‐like neural tumor pattern (2020) (43)
Pigmented neuroectodermal tumour of infancy: an immunohistochemical study (1988) (43)
CIC‐NUTM1 fusion: A case which expands the spectrum of NUT‐rearranged epithelioid malignancies (2018) (43)
Distinctive Dermal Clear Cell Mesenchymal Neoplasm: Clinicopathologic Analysis of Five Cases (2004) (43)
Papillary haemangioma. A distinctive cutaneous haemangioma of the head and neck area containing eosinophilic hyaline globules (2007) (43)
Validating immunohistochemical staining for KIT (CD117). (2003) (43)
The Controversial Nosology of Benign Nerve Sheath Tumors: Neurofilament Protein Staining Demonstrates Intratumoral Axons in Many Sporadic Schwannomas (2007) (42)
Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis (1994) (42)
The difficulty in predicting behavior of smooth-muscle tumors in deep soft tissue. (1995) (41)
Adequacy of pathology resident training for employment: a survey report from the Future of Pathology Task Group. (2007) (41)
Problems in grading soft tissue sarcomas. (2000) (41)
Protocol for the examination of specimens from patients with tumors of soft tissue. (2010) (41)
Rhabdomyosarcomas with primary presentation in the skin. (1993) (40)
Ischemic Fasciitis: Analysis of 44 Cases Indicating an Inconsistent Association With Immobility or Debilitation (2008) (40)
Curriculum content and evaluation of resident competency in anatomic pathology: a proposal. (2003) (40)
Shouldn't we care about the biology of benign tumours? (2014) (40)
Giant cell tumor of soft tissue is genetically distinct from its bone counterpart (2017) (40)
Protocol for the examination of specimens from patients with soft tissue tumors of intermediate malignant potential, malignant soft tissue tumors, and benign/locally aggressive and malignant bone tumors. (2006) (38)
The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma. (1999) (38)
Soft tissue sarcomas that mimic benign lesions. (1995) (37)
Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas (2018) (37)
Recurrent SMARCB1 Inactivation in Epithelioid Malignant Peripheral Nerve Sheath Tumors (2019) (37)
Malignant Peripheral Nerve Sheath Tumor (MPNST) Arising in Diffuse-type Neurofibroma: Clinicopathologic Characterization in a Series of 9 Cases (2015) (36)
Trisomy 21 in solitary fibrous tumor. (1996) (36)
Plexiform spitz nevus: an intradermal spitz nevus with plexiform growth pattern. (1999) (36)
Desmin and CD34 positivity in cellular fibrous histiocytoma: an immunohistochemical analysis of 100 cases (2012) (36)
Cytogenetic analysis of a plexiform fibrohistiocytic tumor. (1990) (36)
Gastrointestinal stromal tumors with prominent signet-ring cell features. (1996) (36)
Fibroblastic Connective Tissue Nevus: A Rare Cutaneous Lesion Analyzed in a Series of 25 Cases (2012) (36)
Intradermal variant of nodular ‘fasciitis’ (1990) (35)
Duplication of chromosome segment 12q15‐24 is associated with atypical lipomatous tumors. A report of the CHAMP collaborative study group (1996) (35)
Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST) (2020) (35)
Recent advances in the diagnosis of soft tissue tumours. (2018) (35)
GRIA2 is a novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling (2014) (34)
Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) (2019) (34)
Molecular prognostication for soft tissue sarcomas: are we ready yet? (2004) (34)
Expression of members of the myf gene family in human rhabdomyosarcomas. (1991) (34)
Expression of Subtype-Specific Group 1 Leiomyosarcoma Markers in a Wide Variety of Sarcomas by Gene Expression Analysis and Immunohistochemistry (2011) (34)
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts (2021) (34)
A morphologic and molecular reappraisal of myoepithelial tumors of soft tissue, bone, and viscera with EWSR1 and FUS gene rearrangements (2020) (33)
Solitary fibrous tumour of the female genital tract: a clinicopathological analysis of 25 cases (2018) (33)
The enigmatic eccrine epithelioma (eccrine syringomatous carcinoma) (1990) (33)
Polymorphous hemangioendothelioma: a report of two cases, one affecting extranodal soft tissues, and review of the literature. (1997) (32)
Report of a symposium on diagnosis and treatment of adult soft tissue sarcomas in the head and neck. (1995) (32)
Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis. (2009) (32)
Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma (2020) (32)
Intradermal Nodular Fasciitis: A Rare Lesion Analyzed in a Series of 24 Cases (2010) (31)
Novel recurrent PHF1‐TFE3 fusions in ossifying fibromyxoid tumors (2019) (31)
Mutations in Hedgehog pathway genes in fetal rhabdomyomas (2013) (31)
Role of BRAFV600E in the first preclinical model of multifocal infiltrating myopericytoma development and microenvironment. (2014) (31)
Challenges in oncology. Case 4. Response of metastatic gastrointestinal stromal tumor including CNS involvement to imatinib mesylate (STI-571). (2002) (30)
Expression of PAX3 Distinguishes Biphenotypic Sinonasal Sarcoma From Histologic Mimics (2018) (30)
Solitary Fibrous Tumor of the Orbit (1995) (30)
Nasal glioma. A rarity. (1986) (30)
Vascular tumors: an update with emphasis on the diagnosis of angiosarcoma and borderline vascular neoplasms. (1996) (29)
Inflammatory leiomyosarcoma may be characterized by specific near‐haploid chromosome changes (1998) (29)
Primary biphasic synovial sarcoma of the orbit. (1992) (29)
Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group. (2002) (28)
A multi-institutional survey of critical diagnoses (critical values) in surgical pathology and cytology. (2008) (28)
Testing for KIT (CD117) in gastrointestinal stromal tumors: another HercepTest? (2002) (28)
Clinicopathologic correlations in gastrointestinal stromal tumors. (2002) (28)
Recently characterized soft tissue tumors that bring biologic insight (2014) (27)
Undifferentiated Sarcomas: What to Do? And Does It Matter? A Surgical Pathology Perspective (2008) (27)
Intravascular glomus tumour: a previously undescribed phenomenon (2005) (27)
Investigative pathology: leading the post-genomic revolution (2012) (27)
Nasopharyngeal angiofibroma: An immunohistochemical study of 32 cases (2005) (27)
Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma (2019) (25)
Pathobiology of soft tissue tumours (1990) (25)
KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized? (2002) (25)
Ectopic hamartomatous thymoma containing myoid cells (1990) (25)
Soft-tissue sarcomas: an update. (1999) (25)
KP1 (CD68) expression in benign neural tumours. Further evidence of its low specificity as a histiocytic/myeloid marker (1993) (25)
Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5+/−;p53+/− mice (2009) (25)
A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas. (2019) (24)
Epithelioid and spindle-celled leiomyosarcoma of the heart. Report of 2 cases and review of the literature. (1999) (24)
Hibernoma Mimicking Atypical Lipomatous Tumor: 64 Cases of a Morphologically Distinct Subset (2018) (24)
How shall we apply the new biology to diagnostics in surgical pathology? (1999) (24)
Cytogenetic and molecular analysis of synovial sarcoma. (1992) (24)
Cutaneous Syncytial Myoepithelioma Is Characterized by Recurrent EWSR1-PBX3 Fusions (2019) (23)
Epithelioid angiomatosis affecting the oral cavity as a first sign of HIV infection (1991) (23)
Dermatofibrosarcoma Protuberans With Unusual Sarcomatous Transformation: A Series of 4 Cases With Molecular Confirmation (2011) (23)
Will We Ever Reliably Predict Prognosis in a Patient with Myxoid and Round Cell Liposarcoma? (1997) (23)
Cutaneous Intraneural Glomus Tumor (1995) (23)
S-100 Protein Staining in Liposarcoma: Its Diagnostic Utility in the High-grade Myxoid (round Cell) Variant (1996) (22)
Recent developments in soft tissue tumours (1995) (22)
Predicting Behavior of Solitary Fibrous Tumor: Are We Getting Closer to More Accurate Risk Assessment? (2013) (22)
Undifferentiated Round Cell Sarcoma with BCOR Internal Tandem Duplications (ITD) or YWHAE fusions: A Clinicopathologic and Molecular Study (2020) (22)
Mechanisms of sunitinib malate (SU) resistance in gastrointestinal stromal tumors (GISTs) (2007) (22)
Synovial metaplasia of the skin (2005) (21)
Nuclear β-Catenin Expression is Frequent in Sinonasal Hemangiopericytoma and Its Mimics (2017) (21)
Malignant giant solitary fibrous tumor of the mediastinum. (2008) (20)
Clustered organization of Krüppel zinc-finger genes at Xp11.23, flanking a translocation breakpoint at OATL1: a physical map with locus assignments for ZNF21, ZNF41, ZNF81, and ELK1. (1994) (20)
Peripheral nerve sheath tumors. A clinicopathologic update. (1990) (19)
Clinical benefit of imatinib in patients (pts) with metastatic gastrointestinal stromal tumors (GIST) negative for the expression of CD117 in the S0033 trial (2005) (19)
[Vascular tumors of the skin and soft tissue. Overview of newly characterized entities and variants]. (1994) (19)
PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells (2020) (19)
Ring chromosomes and low-grade gene amplification in an atypical lipomatous tumor with minimal nuclear atypia. (2003) (19)
[Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course]. (1996) (19)
New entities in cutaneous soft tissue tumours. (1993) (19)
Recent advances in soft tissue tumor diagnosis. (1998) (19)
The Significance of KIT (CD117) in Gastrointestinal Stromal Tumors (2004) (19)
Lipoblastoma-like Tumor of the Vulva: Further Characterization in 8 New Cases (2015) (18)
Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation. (2007) (18)
Malignant mesenchymomas of soft tissue associated with numerous osteoclast-like giant cells mimicking the so-called giant cell variant of “malignant fibrous histiocytoma” (2004) (18)
Myogenic tumors in nevoid Basal cell carcinoma syndrome. (2015) (18)
Spatial Signatures Identify Immune Escape via PD-1 as a Defining Feature of T-cell/Histiocyte-rich Large B-cell Lymphoma. (2020) (18)
Clonal evolution of resistance to imatinib (IM) in patients (pts) with gastrointestinal stromal tumor (GIST): molecular and radiologic evaluation of new lesions. (2004) (18)
Cellular fibrous histiocytoma of the skin: Evidence of a clonal process with different karyotype from dermatofibrosarcoma (1997) (17)
Critical Diagnoses in Surgical Pathology: A Retrospective Single-institution Study to Monitor Guidelines for Communication of Urgent Results (2009) (17)
PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours (2018) (17)
Myolipoma of Soft Tissue: Clinicopathologic Analysis of 34 Cases (2017) (17)
JNCCN NCCN Task Force Report : Optimal Management of Patients with Gastrointestinal Stromal Tumor ( GIST ) — Update of the NCCN Clinical Practice Guidelines (2007) (17)
The clinical role of molecular genetics in soft tissue tumor pathology (1997) (16)
Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas (2021) (16)
Chondromyxoid Fibroma Arising in Craniofacial Sites: A Clinicopathologic Analysis of 25 Cases (2018) (16)
Cartilaginous tumours of soft tissue. (1988) (16)
The Histologic, Genetic, and Biological Relationships between Dermatofibrosarcoma Protuberans and Giant Cell Fibroblastoma: An Unexpected Story (1997) (16)
[Pigmented fibrosarcomatous dermatofibrosarcoma protuberans (Bednar tumor). 3 case reports, analogy with the "conventional" type and review of the literature]. (1997) (15)
Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms (2021) (15)
Intra-abdominal desmoplastic small-cell tumours with divergent differentiation. Report of two cases and review of the literature. (1992) (15)
Neonatal Rhabdomyosarcoma Misdiagnosed as a Congenital Hemangioma (2011) (15)
Head and Neck Round Cell Sarcomas: A Comparative Clinicopathologic Analysis of 2 Molecular Subsets: Ewing and CIC-Rearranged Sarcomas (2017) (15)
Fibroeptithelial Stromal Polyps of Vulvovaginal Tissue (1998) (15)
Meningothelial Proliferations in Mature Cystic Teratom of the Ovary: Evidence for the Common Presence of Cranially Derived Tissues Paralleling Anterior Embryonic Plate Development. An Analysis of 25 Consecutive Cases (2010) (14)
Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma (2020) (14)
Liposarcoma subtypes: identification with computed tomography and ultrasound-guided percutaneous needle biopsy (2005) (14)
Myofibroblastoma of the Breast: A Distinctive Benign Stromal Tumor (1999) (14)
Primary intra‐articular sarcoma: a clinicopathological study of 15 cases (2016) (14)
5‐Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms (2017) (14)
Soft tissue tumours: the impact of cytogenetics and molecular genetics. (1997) (14)
Recent developments in soft tissue tumors. (1995) (14)
The role of cytogenetics and molecular genetics in soft tissue tumour diagnosis—a realistic appraisal (2005) (13)
Pleomorphic fibroma and dermal atypical lipomatous tumor: are they related? (2013) (13)
Phase II Study of the Antiangiogenic Agent SU 5416 in Patients with Advanced Soft Tissue Sarcomas (2004) (13)
Malignant paraganglioma of the uterus (2005) (13)
The role of cytogenetics and molecular genetics in soft tissue tumour diagnosis—a realistic appraisal (2005) (13)
Incidence and reasons for dose modification of standard-dose vs. high-dose imatinib mesylate (IM) in the Phase III Intergroup Study S0033 of patients (pts) with unresectable or metastatic gastrointestinal stromal tumor (GIST) (2005) (13)
Paratesticular Rhabdomyoma: A Morphologically Distinct Sclerosing Variant (2013) (13)
Hybrid Schwannoma-Perineurioma Frequently Harbors VGLL3 Rearrangement (2021) (13)
Clear Cell Tumor With Melanocytic Differentiation and ACTIN-MITF Translocation: Report of 7 Cases of a Novel Entity. (2020) (13)
Primary gastrointestinal Liposarcoma - a Clinicopathologic study of 8 cases of a rare entity. (2019) (12)
The non-neoplastic nature of spindle cell hemangioendothelioma. (1992) (12)
Fibrous and myofibroblastic tumors (2002) (12)
[Primary primitive neuroectodermal tumor of the kidney in an adult. Clinico-pathologic and immunohistochemical case report]. (1994) (12)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-2004. A 68-year-old man with a large retroperitoneal mass. (2004) (12)
DNA copy number changes in tumors within the spectrum of cellular, atypical, and metastasizing fibrous histiocytoma. (2014) (12)
Immunohistochemistry and DNA flow cytometry in soft-tissue sarcomas. (1995) (11)
Experimental microvascular autogenous vein grafts for arterial defects: II. A histopathologic study of the grafts (1988) (11)
Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling (2018) (11)
Deep fibrous histiocytoma with a clonal karyotypic alteration: molecular cytogenetic characterization of a t(16;17)(p13.3;q21.3). (2010) (11)
Melanotic schwannoma arising in association with nevus of Ota: 2 cases suggesting a shared mechanism. (2009) (11)
High rates of histopathologic discordance in sarcoma with implications for clinical care. (2011) (11)
Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1–ALK fusions (2020) (10)
NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25‐case cohort study (2020) (10)
Amplification and Over-Expression of the MDM2 Gene in Human Soft Tissue Tumours (1997) (10)
Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion–negative rhabdomyosarcoma: A report from the Children's Oncology Group (2018) (10)
The value of secondary pathology review. (2016) (10)
Verrucous Hemangioma (1995) (10)
Smooth muscle tumors of the external genitalia (1991) (9)
Visceral intravascular capillary hemangioma. (1987) (9)
QBEnd/10: A useful, but by no means specific, marker of kaposi's sarcoma (1990) (9)
What is needed to satisfy the American College of Surgeons Commission on Cancer (COC) requirements for the pathologic reporting of cancer specimens? (2003) (9)
Calcifying and ossifying soft tissue lesions presenting in the skin. (1996) (9)
Mammary Parenchymal Angiosarcoma after Breast‐Conserving Treatment for Invasive High‐Grade Ductal Carcinoma (2004) (9)
Borderline Malignancy in Soft Tissue Neoplasia (1998) (8)
Newer entities in soft tissue tumours (1997) (8)
Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis (2021) (8)
Translocation of the HMGI-C (HMGA2) gene in a benign mesenchymoma (chondrolipoangioma) (2002) (8)
Evaluation of imatinib mesylate (IM) in patients with large volume gastrointestinal stromal tumors (GISTs) (2007) (8)
Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? (2001) (7)
PARACHORDOMAS. AUTHORS' REPLY (1997) (7)
A cutaneous spindle-cell lesion. (2001) (7)
Atypical Pleomorphic Lipomatous Tumor (2021) (7)
A morphologic and molecular reappraisal of genetically confirmed myoepithelial tumors of soft tissue, bone and viscera. (2020) (7)
Human Cancer Biology PD-L 1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies (2013) (7)
Primary Giant Cell Tumors of Soft Tissue (2000) (7)
HISTOPATHOLOGIC EVALUATION OF ATYPICAL NEUROFIBROMATOUS TUMORS AND THEIR TRANSFORMATION INTO MALIGNANT PERIPHERAL NERVE SHEATH TUMOR IN NEUROFIBROMATOSIS 1 PATIENTS – A CONSENSUS OVERVIEW (2017) (7)
Symposium on Errors, Error Reduction, and Critical Values in Anatomic Pathology (2009) (7)
The use of immunohistochemistry in the diagnosis of soft tissue tumours (1986) (6)
Diagnostically Challenging Spindle Cell Neoplasms of the Retroperitoneum. (2015) (6)
[The histological features of local recurrences of soft tissue sarcomas]. (1994) (6)
Intra-Canal Optic Nerve Cavernous Haemangioma: A Case Report & Review Of The Literature. (2019) (6)
Large cell calcifying Sertoli cell tumour: a contemporary multi‐institutional case series highlighting the diagnostic utility of PRKAR1A immunohistochemistry (2021) (6)
Low-Grade Myxofibrosarcoma (1998) (6)
Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypes (2021) (6)
Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions (2021) (6)
[Early stage Stewart-Treves syndrome: report of 2 cases and review of the literature]. (1996) (6)
Critical diagnoses (critical values) in anatomic pathology. (2006) (5)
9404 ORAL Long-term Survival on S0033 – a Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate at Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumours (GISTs) (2011) (5)
Cutaneous Myoepithelioma? (2000) (5)
Lymphangiomatosis of the Limbs (1995) (5)
Pseudoendocrine Sarcoma (2021) (5)
Sarcomatoid Yolk Sac Tumor Harbors Somatic Mutations That Are Otherwise Rare in Testicular Germ Cell Tumors (2022) (5)
Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development (2013) (4)
Gastroesophageal Glomus Tumors (2022) (4)
Monosomy 22 in a malignant peripheral nerve sheath tumour of the kidney in childhood: a genetic link with other malignant paediatric renal neoplasms? (1995) (4)
Morphologically malignant nodular fasciitis with CALD1-USP6 fusion (2021) (4)
Testing for KIT (CD117) in gastrointestinal stromal tumors: another HercepTest? (2002) (4)
Angiomatoid fibrous histiocytoma. (1992) (4)
Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin? (2009) (4)
Congenital hand lesion. (2007) (4)
Solitary fibrous tumour arising at unusual sites (1992) (4)
Cutaneous Melanocytic Tumor With CRTC1::TRIM11 Translocation (2022) (4)
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans (DOI: 10.1016/j.ccr.2006.03.028) (2006) (4)
NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 4.2020 (2020) (3)
Immunohistochemistry in diagnosis of soft tissue sarcomas and new techniques in soft tissue tumour pathology. (1995) (3)
Leiomyosarcoma with osteoclast‐like giant cells (1993) (3)
Calcifying nested stromal–epithelial tumor: a clinicopathologic and molecular genetic study of eight cases highlighting metastatic potential and recurrent CTNNB1 and TERT promoter alterations (2021) (3)
MFH - Factoid? [1] (1993) (3)
Abstract B184: HSP90 inhibitor STA‐9090 potently suppresses heterogeneous KIT kinase‐domain mutations responsible for gastrointestinal stromal tumor progression during imatinib therapy (2009) (3)
Molecular correlates of male germ cell tumors with overgrowth of components resembling somatic malignancies (2022) (3)
Superficial CD34-Positive Fibroblastic Tumor (2022) (3)
Kinase Mutat ions and Imat inib Response in Pat ients With Metastat ic Gastro intes t inal Stromal Tumor (2003) (3)
A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report (2021) (2)
Renal Perivascular Epithelioid Cell Tumors [(PEComa), so Called Epithelioid Angiomyolipoma (EAML)]: Analysis of 61 Cases Including 44 with Pure/Predominant Epithelioid (P-PEComa) Morphology and Parameters Associated with Malignant Outcome (2009) (2)
TDM35—a new monoclonal antibody to the XH1 cervical carcinoma cell line. Characterization and immunoperoxidase localization in benign and malignant tissues (1992) (2)
Abstracts from USCAP 2021: Bone and Soft Tissue Pathology (33-65) (2021) (2)
Histological characteristics of local recurrences in soft tissue sarcomas. (1995) (2)
Plexiform Myofibroblastoma (2020) (2)
Integrated Genetic and Topological Analysis Reveals a Hodgkin-like Mechanism of Immune Escape in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma (2018) (2)
NTRK-Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification (2022) (2)
Lymphomas and Virus-Associated Malignancies PD-L 1 Expression Is Characteristic of a Subset of Aggressive B-cell (2013) (2)
Abstract 952: Protein kinase C theta (PKCθ) and c-Jun regulate proliferation through cyclin D1 in KIT-independent gastrointestinal stromal tumors (2011) (2)
KIT (CD117) immunostaining and treatment with STI-571 (2001) (2)
Distinctive Nested Glomoid Neoplasm (2022) (2)
Postirradiation malignant fibrous histiocytoma expressing cytokeratin: a question of diagnostic criteria. (1989) (2)
Rare soft tissue sarcomas. (1995) (2)
Superficial CD 34-Positive Fibroblastic Tumor A Clinicopathologic , Immunohistochemical , and Molecular Study of 59 Cases (2022) (1)
Vascular neoplasms of the breast (2021) (1)
Low-grade Fibromyxoid Sarcoma of the Vulva and Vagina (2022) (1)
Distantly Metastatic Retinoblastoma to Soft Tissue and Bone: A Challenging Diagnosis Highlighting the Utility of CRX. (2020) (1)
Genome-wide transcriptome analysis of nerve sheath tumors (2006) (1)
Board certification in anatomic pathology. (2003) (1)
Correspondence Re: O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, Swanson PE, Dehner LP, Humphrey PA, Pfeifer JD: Malignant Peripheral Nerve Sheath Tumors With T(X;18). A Pathologic and Molecular Genetic Study. Mod Pathol 2000;13:1336–46 (2001) (1)
Follicular dentritic cell sarcoma. (2008) (1)
Leiomyosarcomata of the Inferior Vena Cava and Large Veins (1991) (1)
Chondrolipoma of the tonsil. (2016) (1)
Intradermal Spindle Cell/Pleomorphic Lipoma (2000) (1)
PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion (2022) (1)
Tumors showing skeletal muscle differentiation. Introduction. (1994) (1)
Angiosarcoma Arising in Hemangioma/Vascular Malformation (2002) (1)
Myoid gonadal stromal tumours are characterised by recurrent chromosome‐level copy number gains: molecular assessment of a multi‐institutional series (2022) (1)
Correlation of KIT and PDGFRA mutation status with sunitinib activity in imatinib-resistant GIST (2006) (1)
Vulvar mesenchymal neoplasms and tumor-like conditions (2009) (1)
An Atlas of Gross Pathology (1987) (1)
Molecular and immunohistochemical characterisation of mesothelioma of the tunica vaginalis* (2022) (1)
GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics (2023) (1)
Abstract LB-270: Genomic amplification of c-Jun activates genes that promote proliferation and cell migration in liposarcoma (2012) (0)
Dermatofibrosarcoma protuberans (1984) (0)
The evolving classification of soft tissue tumours – what’s next? (2015) (0)
USCAP COMPANION MEETING INTERNATIONAL SOCIETY OF BREAST PATHOLOGY DENVER, March 2 2008 SPINDLE CELL & VASCULAR LESIONS OF THE BREAST AND THEIR DIFFERENTIAL DIAGNOSIS (2008) (0)
Soft Tissue Aneurysmal Bone Cyst (2001) (0)
7506 ORAL Up to 6 years follow-up of patients receiving imatinib mesylate (Glivec) to treat unresectable or metastatic gastrointestinal stromal tumors (GISTs) (2007) (0)
Authors' reply (1997) (0)
Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma , Version 2 . 2019 CE (2019) (0)
A Clinicopathologic and Molecular Characterization of Uterine Sarcomas Classified as Malignant PEComa (2023) (0)
Comprar Diagnostic Histopathology of Tumors | Christopher D. M. Fletcher | 9780443074349 | Churchill Livingstone (2007) (0)
Comprar Diagnostic Histopathology of Tumors: 2 Volume Set, 4th Edition | Christopher D.M. Fletcher | 9781437715347 | Churchill Livingstone (2013) (0)
Editorial (2006) (0)
Primary Clear Cell Sarcoma of Bone (2022) (0)
Lenalidomide and Rituximab Maintenance Therapy after Front-Line Induction Chemoimmunotherapy in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (2019) (0)
Current management of metastatic gastrointestinal stromal tumor: a case report. (2003) (0)
Editorial (1996) (0)
What Is Needed to Satisfy the American College of Surgeons Commission on Cancer Requirements for the Pathologic Reporting of Cancer Specimens (2003) (0)
Smooth muscle tumours of the external genitalia. Author's replys (1992) (0)
Proposed criteria for malignancy in glomus tumors (2001) (0)
Angiomyxoma of the Breast (2022) (0)
Identification of COL1A1/2 Mutations and Fusions With Noncoding RNA Genes in Bizarre Parosteal Osteochondromatous Proliferation (Nora Lesion). (2023) (0)
Molecular Correlates of Aggressive Behavior and Biologic Progression in Testicular Sertoli Cell Tumor. (2023) (0)
Mesenchymal lesions (and MIMICS) in the breast (2015) (0)
A Phase I/II Study of Ibrutinib and Ixazomib in Relapsed/Refractory Mantle Cell Lymphoma: PrE0404 (2019) (0)
THE EVOLUTION OF SOFT TISSUE TUMOUR TAXONOMY : WHAT STILL NEEDS TO BE DONE ? (2008) (0)
Novel MALAT1-GL11 Oncogenic Fusion in Plexiform Angiomyxoid Myelofibroblastic Tumors of the Stomach (2016) (0)
Atlas of Surgical Pathology (1992) (0)
Tyrosine kinases as possible therapeutic targets in pulmonary artery intimal sarcoma (2007) (0)
Ocular Manifestations of Seckel Syndrome (2001) (0)
"E-MGNET": Extra-Enteric Malignant Gastrointestinal Neuroectodermal Tumor- A Clinicopathological and Molecular Genetic Study of 11 Cases. (2023) (0)
Plexiform fibrohistiocytic tumour in a child's foot (1991) (0)
HEMANGIOPERICYTOMA , TRUE PERICYTIC TUMORS AND MIMICS (2007) (0)
Abstracts from USCAP 2021: Bone and Soft Tissue Pathology (33-65) (2021) (0)
Pulmonary “Inflammatory Leiomyosarcomas” Are Indolent Tumors With Diploid Genomes and No Convincing Rhabdomyoblastic Differentiation (2021) (0)
Tumorigenesis and Neoplastic Progression Recurrent Rearrangement of the PHF 1 Gene in Ossifying Fibromyxoid Tumors (2012) (0)
Inside the USCAP Journals (2016) (0)
New insights in soft tissue tumours (2015) (0)
Epithelioid and Spindle Cell Hemangioma (2022) (0)
Symposium 14: Controversial topics in soft tissue pathology (2002) (0)
Chapter 37 – Soft-Tissue Sarcomas (2008) (0)
The role of cytogenetic and molecular analysis in the classification of benign/borderline soft tissue tumours (1992) (0)
Micronodular PEComas of the appendix (2021) (0)
44 – Soft Tissue Sarcomas (2015) (0)
High Frequency of Ovarian Cyst Development in Vhl2B/+;Snf5+/- Mice. (2018) (0)
The T-Cell Activation Markers CD 30 and OX 40 / CD 134 Are Expressed in Nonoverlapping Subsets of Peripheral T-Cell Lymphoma (1999) (0)
Large cell calcifying Sertoli cell tumour: molecular and immunohistochemical assessment of a series comprising non-metastasising and metastasising neoplasms. (2023) (0)
Mid-line presentation of cervical lymphomata (1990) (0)
In Response to “Reexamining the molecular findings in specialized stromal tumors of the prostate” (2021) (0)
3.P.06 HAEMANGIOPERICYTOMA OF BONE: REAL OR IMAGINED? (2010) (0)
Trends in Cutaneous Connective Tissue Tumors (1989) (0)
Why pathology? (2001) (0)
Sarcomatoid Carcinomas of Breast (2007) (0)
7503 ORAL KIT mutations and sunitinib resistance in gastrointestinal stromal tumors (GISTs) (2007) (0)
Two categories of synovial sarcoma defined by t(X;18) breakpoints on chromosome Xp (1994) (0)
Mesenchymal lesions of the breast (2022) (0)
‘Inflammatory myofibroblastic tumour’‐like dedifferentiation of anaplastic lymphoma kinase‐rearranged lung adenocarcinoma (2016) (0)
Abstract 1359: Establishment and characterization of mouse malignant rhabdoid tumor cell lines (2012) (0)
Molecular assessment of paratesticular rhabdomyomas demonstrates recurrent findings, including a novel H3C2 p.K37I mutation (2022) (0)
Diagnostic pitfalls in soft tissue pathology (2015) (0)
Inflammatory and Nested Testicular Sex Cord Tumor (2023) (0)
Soft tissue sarcoma incidence trends and demographic patterns by histologic type in the Surveillance, Epidemiology, and End Results (SEER) Program, 1978-2001: An analysis of 26,758 cases (2005) (0)
Clinicopathologic and molecular spectrum of testicular sex cord-stromal tumors not amenable to specific histopathologic subclassification (2022) (0)
Editorial The Significance of KIT ( CD 117 ) in Gastrointestinal Stromal Tumors (2004) (0)
How should surgical pathology evolve (2015) (0)
Expert Commentary. (2002) (0)
rapeutic Targets in Intimal Sarcoma (2010) (0)
Cases in Consultation (2000) (0)
Ampli ® cation and over-expression of the MDM 2 gene in human soft tissue tumours (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Christopher D. M. Fletcher?

Christopher D. M. Fletcher is affiliated with the following schools:

University of Helsinki
University of Lausanne
Oregon Health & Science University

Christopher D. M. Fletcher's Academic­Influence.com Rankings

Why Is Christopher D. M. Fletcher Influential?

Christopher D. M. Fletcher's Published Works

Published Works

What Schools Are Affiliated With Christopher D. M. Fletcher?

Christopher D. M. Fletcher's AcademicInfluence.com Rankings